Summit Global Investments »

AstraZeneca shares owned by Summit Global Investments

Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by Summit Global Investments from 13F filings

Historical chart of Summit Global Investments investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by Summit Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by Summit Global Investments

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.2M 54k 77.92

More positions owned by Summit Global Investments

RBB Sgi Enhanced Cor (USDX)
RBB Sgi Us Large Cap (SGLC)
RBB Sgi Enhanced Glb (GINX)
RBB Sgi Diversi Tac (DYTA)
Ishares Tr Core Us Aggbd Et (AGG)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Progressive Corporation (PGR)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Iboxx Hi Yd Etf (HYG)
NVIDIA Corporation (NVDA)
United Therapeutics Corporation (UTHR)
Merck & Co (MRK)
Colgate-Palmolive Company (CL)

View all positions for Summit Global Investments

Top funds holding AstraZeneca

T. Rowe Price Associates
PRIMECAP Management Company
Capital Research and Management Company - Division 3
Franklin Resources
Jennison Associates
Sanders Capital
Goldman Sachs Group
Morgan Stanley
Fisher Investments
Atlantic Trust
Bank of America Corporation
BlackRock
Capital World Investors
BlackRock
GQG Partners

View all funds holding AstraZeneca